1[1]Denny W A.The role of hypoxia-activated prodru gs in cancer therapy[J].Lancet Oncol 2000;1(1):25-9.
2[2]Brown JM.Hypoxic cytotoxic agents:a new approach to cancer chemotherapy[J].Drug Resist Updat 2000;3(1):7-13.
3[3]Peters KB,Wang H,Brown JM,Iliakis G.Inhibition of DNA replication by tirapazamine[J].Cancer Res.2001;61(14):5425-31.
4[4]Delahoussaye YM,Evans JW,Brown JM.Metabolism of tirapazamine by mulatple reductases in the nucleus[J].Biochem Pharmacol.2001;62(9):1201-9.
5[5]Ban F,Gauld JW,Boyd RJ.Modeling the action of an antitumor drug:a density functional theory study of the mechanism of tirapazamige[J].J Am Chem Soc.2001;123(30):7320-5.
6[6]Adam MF,Gabalski EC,Bloch DA,et al.Tissue oxygen distrbution in head and neck cancer patients[J].Head Neck,1999;21:146-53.
7[7]Vaupel P,Schlenger K,Knoop C,et al.Oxygenation of human tumors:Evaluation of tissue oxygen distribution in breast cancers by computerized O2tension measurenents[J].Cancer Res,1991;51:3316-2.
8[8]Goleberg,Z,Evans J,Birrell G,Brown JM.An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin[J].Int J Radiat Oncol Phys.2001;49(1):175-82.
9[9]Masunaga,S,Ono K,Nishimura Y,Kanamori S,et al.Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent(TNP-470)treated tumors-reference to the effect on intratumor quiescent cells[J].Int J Radiat Oncol Biol Phys,2000;47(3):799-807.
10[10]Cemazar M,Parkins CS,Holder AL,et al.Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice[J].Anticancer Res.2001;21(2A):1151-6.
